Symbol:
Fpr2
Name:
formyl peptide receptor 2
RGD ID:
1584013
Description:
Enables RAGE receptor binding activity. Involved in dentinogenesis. Predicted to be located in cytoplasm. Predicted to be active in plasma membrane. Biomarker of dentin caries. Orthologous to human FPR2 (formyl peptide receptor 2); INTERACTS WITH 17beta-estradiol; amphetamine; bisphenol A.
Type:
protein-coding
RefSeq Status:
VALIDATED
Previously known as:
Alx; formyl peptide receptor 2-like; formyl peptide receptor, related sequence 2; formyl peptide receptor, related sequence 2-like; formyl peptide receptor-like 1; Fpr-rs2; Fpr2l; Fprl1; lipoxin A 4 receptor; LOC690158; Lxa4r; similar to formyl peptide receptor, related sequence 2
RGD Orthologs
Alliance Orthologs
More Info
more info ...
More Info
Related Pseudogenes:
Fpr2-ps4
Latest Assembly:
GRCr8 - GRCr8 Assembly
Position:
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 1 67,449,637 - 67,458,272 (+) NCBI GRCr8 mRatBN7.2 1 58,776,592 - 58,785,227 (+) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 1 58,776,752 - 58,786,019 (+) Ensembl mRatBN7.2 Ensembl Rnor_6.0 1 59,800,558 - 59,809,507 (-) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 1 59,800,984 - 59,802,401 (-) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 1 60,719,375 - 60,727,932 (-) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 1 56,622,816 - 56,624,057 (+) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 Celera 1 54,955,259 - 54,964,212 (+) NCBI Celera Cytogenetic Map 1 q12 NCBI
JBrowse:
View Region in Genome Browser (JBrowse)
Model
Only show annotations with direct experimental evidence (0 objects hidden)
Fpr2 Rat (1->4)-beta-D-glucan multiple interactions ISO Fpr2 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of FPR2 mRNA CTD PMID:36331819 Fpr2 Rat 17beta-estradiol multiple interactions EXP 6480464 [bisphenol A co-treated with Estradiol] results in increased expression of FPR2 mRNA CTD PMID:26496021 Fpr2 Rat 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Fpr2 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of FPR2 mRNA CTD PMID:21570461 Fpr2 Rat 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO FPR2 (Homo sapiens) 6480464 Tetrachlorodibenzodioxin results in decreased expression of FPR2 mRNA CTD PMID:27913140 Fpr2 Rat 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Fpr2 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in increased expression of FPR2 mRNA CTD PMID:26290441 Fpr2 Rat 2,4-dibromophenyl 2,4,5-tribromophenyl ether affects expression ISO Fpr2 (Mus musculus) 6480464 2 more ... CTD PMID:38648751 Fpr2 Rat 4,4'-diaminodiphenylmethane decreases expression ISO Fpr2 (Mus musculus) 6480464 4 and 4'-diaminodiphenylmethane results in decreased expression of FPR2 mRNA CTD PMID:18648102 Fpr2 Rat 4-hydroxyphenyl retinamide increases expression ISO Fpr2 (Mus musculus) 6480464 Fenretinide results in increased expression of FPR2 mRNA CTD PMID:28973697 Fpr2 Rat acetylsalicylic acid increases expression ISO FPR2 (Homo sapiens) 6480464 Aspirin results in increased expression of FPR2 CTD PMID:19597002 Fpr2 Rat acetylsalicylic acid multiple interactions ISO FPR2 (Homo sapiens) 6480464 [Aspirin results in increased abundance of lipoxin A4] which results in increased expression of FPR2 CTD PMID:19597002 Fpr2 Rat aflatoxin B1 increases methylation ISO FPR2 (Homo sapiens) 6480464 Aflatoxin B1 results in increased methylation of FPR2 gene CTD PMID:27153756 Fpr2 Rat all-trans-retinoic acid increases expression ISO FPR2 (Homo sapiens) 6480464 Tretinoin results in increased expression of FPR2 mRNA CTD PMID:33167477 Fpr2 Rat amphetamine increases expression EXP 6480464 Amphetamine results in increased expression of FPR2 mRNA CTD PMID:30779732 Fpr2 Rat antirheumatic drug decreases expression ISO FPR2 (Homo sapiens) 6480464 Antirheumatic Agents results in decreased expression of FPR2 mRNA CTD PMID:24449571 Fpr2 Rat arsane affects methylation ISO FPR2 (Homo sapiens) 6480464 Arsenic affects the methylation of FPR2 gene CTD PMID:25304211 Fpr2 Rat arsane decreases expression ISO Fpr2 (Mus musculus) 6480464 Arsenic results in decreased expression of FPR2 mRNA CTD PMID:19654921 Fpr2 Rat arsenic atom affects methylation ISO FPR2 (Homo sapiens) 6480464 Arsenic affects the methylation of FPR2 gene CTD PMID:25304211 Fpr2 Rat arsenic atom decreases expression ISO Fpr2 (Mus musculus) 6480464 Arsenic results in decreased expression of FPR2 mRNA CTD PMID:19654921 Fpr2 Rat Azoxymethane multiple interactions ISO Fpr2 (Mus musculus) 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of FPR2 mRNA CTD PMID:29950665 Fpr2 Rat benzo[a]pyrene affects expression ISO Fpr2 (Mus musculus) 6480464 Benzo(a)pyrene affects the expression of FPR2 mRNA CTD PMID:22342234 Fpr2 Rat benzo[a]pyrene increases methylation ISO FPR2 (Homo sapiens) 6480464 Benzo(a)pyrene results in increased methylation of FPR2 5' UTR and Benzo(a)pyrene results in increased methylation of FPR2 promoter CTD PMID:27901495 Fpr2 Rat benzo[a]pyrene increases expression ISO Fpr2 (Mus musculus) 6480464 Benzo(a)pyrene results in increased expression of FPR2 mRNA CTD PMID:22228805 Fpr2 Rat bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with Estradiol] results in increased expression of FPR2 mRNA CTD PMID:26496021 Fpr2 Rat bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of FPR2 mRNA CTD PMID:25181051 Fpr2 Rat carbon nanotube affects expression ISO Fpr2 (Mus musculus) 6480464 Nanotubes and Carbon analog affects the expression of FPR2 mRNA CTD PMID:25554681 Fpr2 Rat carbon nanotube increases expression ISO Fpr2 (Mus musculus) 6480464 Nanotubes and Carbon results in increased expression of FPR2 mRNA CTD PMID:25554681 Fpr2 Rat CGP 52608 multiple interactions ISO FPR2 (Homo sapiens) 6480464 CGP 52608 promotes the reaction [RORA protein binds to FPR2 gene] CTD PMID:28238834 Fpr2 Rat chloroprene decreases expression ISO Fpr2 (Mus musculus) 6480464 Chloroprene results in decreased expression of FPR2 mRNA CTD PMID:23125180 Fpr2 Rat cisplatin increases expression ISO FPR2 (Homo sapiens) 6480464 Cisplatin results in increased expression of FPR2 mRNA CTD PMID:27594783 Fpr2 Rat cobalt dichloride increases expression ISO FPR2 (Homo sapiens) 6480464 cobaltous chloride results in increased expression of FPR2 mRNA CTD PMID:23052192 Fpr2 Rat cyclophosphamide increases expression ISO Fpr2 (Mus musculus) 6480464 Cyclophosphamide results in increased expression of FPR2 mRNA CTD PMID:15331540 Fpr2 Rat cyclosporin A increases methylation ISO FPR2 (Homo sapiens) 6480464 Cyclosporine results in increased methylation of FPR2 promoter CTD PMID:27989131 Fpr2 Rat dextran sulfate multiple interactions ISO Fpr2 (Mus musculus) 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of FPR2 mRNA CTD PMID:29950665 Fpr2 Rat Dibutyl phosphate affects expression ISO FPR2 (Homo sapiens) 6480464 di-n-butylphosphoric acid affects the expression of FPR2 mRNA CTD PMID:37042841 Fpr2 Rat diclofenac increases expression ISO Fpr2 (Mus musculus) 6480464 Diclofenac results in increased expression of FPR2 mRNA CTD PMID:26934552 Fpr2 Rat lipopolysaccharide increases expression ISO Fpr2 (Mus musculus) 6480464 Lipopolysaccharides results in increased expression of FPR2 mRNA CTD PMID:21831303 Fpr2 Rat lipoxin A4 multiple interactions ISO FPR2 (Homo sapiens) 6480464 [Aspirin results in increased abundance of lipoxin A4] which results in increased expression of FPR2 and lipoxin A4 analog binds to and results in decreased activity of FPR2 protein CTD PMID:12594298 and PMID:19597002 Fpr2 Rat lipoxin A4 multiple interactions EXP 6480464 lipoxin A4 inhibits the reaction [lipopolysaccharide and E coli O55-B5 results in increased expression of FPR2 mRNA] CTD PMID:21765620 Fpr2 Rat lipoxin A4 increases activity ISO FPR2 (Homo sapiens) 6480464 lipoxin A4 results in increased activity of FPR2 CTD PMID:12594298 Fpr2 Rat methotrexate decreases expression ISO FPR2 (Homo sapiens) 6480464 Methotrexate results in decreased expression of FPR2 mRNA CTD PMID:17400583 Fpr2 Rat nickel atom decreases expression ISO FPR2 (Homo sapiens) 6480464 Nickel results in decreased expression of FPR2 mRNA CTD PMID:23195993 Fpr2 Rat ozone decreases expression ISO Fpr2 (Mus musculus) 6480464 Ozone results in decreased expression of FPR2 mRNA CTD PMID:29471542 Fpr2 Rat paracetamol affects expression ISO Fpr2 (Mus musculus) 6480464 Acetaminophen affects the expression of FPR2 mRNA CTD PMID:17562736 Fpr2 Rat perfluorooctane-1-sulfonic acid multiple interactions ISO Fpr2 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of FPR2 mRNA CTD PMID:36331819 Fpr2 Rat Phenelzine affects expression ISO Fpr2 (Mus musculus) 6480464 Phenelzine affects the expression of FPR2 mRNA CTD PMID:31249575 Fpr2 Rat pirinixic acid decreases expression ISO Fpr2 (Mus musculus) 6480464 pirinixic acid results in decreased expression of FPR2 mRNA CTD PMID:20813756 Fpr2 Rat protein kinase inhibitor multiple interactions ISO FPR2 (Homo sapiens) 6480464 Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of FPR2 mRNA] CTD PMID:28003376 Fpr2 Rat quercetin increases expression ISO FPR2 (Homo sapiens) 6480464 Quercetin results in increased expression of FPR2 mRNA CTD PMID:15309432 Fpr2 Rat silicon dioxide increases expression ISO Fpr2 (Mus musculus) 6480464 Silicon Dioxide results in increased expression of FPR2 mRNA CTD PMID:23221170 Fpr2 Rat sodium arsenite decreases expression ISO Fpr2 (Mus musculus) 6480464 sodium arsenite results in decreased expression of FPR2 mRNA CTD PMID:37682722 Fpr2 Rat sulforaphane increases expression ISO FPR2 (Homo sapiens) 6480464 sulforaphane results in increased expression of FPR2 mRNA CTD PMID:26833863 Fpr2 Rat tamoxifen affects expression ISO Fpr2 (Mus musculus) 6480464 Tamoxifen affects the expression of FPR2 mRNA CTD PMID:20937368 Fpr2 Rat tetrachloromethane increases expression ISO Fpr2 (Mus musculus) 6480464 Carbon Tetrachloride results in increased expression of FPR2 mRNA CTD PMID:31919559 Fpr2 Rat titanium dioxide affects expression ISO Fpr2 (Mus musculus) 6480464 titanium dioxide affects the expression of FPR2 mRNA CTD PMID:23557971 Fpr2 Rat titanium dioxide multiple interactions ISO Fpr2 (Mus musculus) 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of FPR2 mRNA CTD PMID:29950665 Fpr2 Rat tremolite asbestos increases expression ISO Fpr2 (Mus musculus) 6480464 tremolite results in increased expression of FPR2 mRNA CTD PMID:29279043 Fpr2 Rat trimellitic anhydride increases expression ISO Fpr2 (Mus musculus) 6480464 trimellitic anhydride results in increased expression of FPR2 mRNA CTD PMID:19042947 Fpr2 Rat triphenyl phosphate affects expression ISO FPR2 (Homo sapiens) 6480464 triphenyl phosphate affects the expression of FPR2 mRNA CTD PMID:37042841 Fpr2 Rat triptonide increases expression ISO Fpr2 (Mus musculus) 6480464 triptonide results in increased expression of FPR2 mRNA CTD PMID:33045310 Fpr2 Rat tungsten decreases expression ISO Fpr2 (Mus musculus) 6480464 Tungsten results in decreased expression of FPR2 mRNA CTD PMID:30912803 Fpr2 Rat XL147 multiple interactions ISO Fpr2 (Mus musculus) 6480464 [N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of FPR2 mRNA CTD PMID:27935865
Biological Process
adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (IEA,IGI,ISO) astrocyte activation (IGI) calcium-mediated signaling (IEA,ISO) cell surface receptor signaling pathway (IEA,ISO) cellular response to amyloid-beta (IDA,IEA,ISO) chemotaxis (IEA) complement receptor mediated signaling pathway (IBA) defense response to bacterium (IEA,ISO) dentinogenesis (IEP) G protein-coupled receptor signaling pathway (IEA,ISO) immune response-regulating cell surface receptor signaling pathway (IEA,ISO) inflammatory response (IBA) microglial cell activation (IGI) negative regulation of inflammatory response (IEA,ISO) negative regulation of neuron apoptotic process (IMP) phospholipase C-activating G protein-coupled receptor signaling pathway (IBA,ISO) positive chemotaxis (ISO) positive regulation of cytosolic calcium ion concentration (IBA) positive regulation of ERK1 and ERK2 cascade (IEA,IGI,ISO) positive regulation of innate immune response (IEA,ISO) positive regulation of monocyte chemotaxis (IEA,ISO) positive regulation of phagocytosis (IEA,ISO) positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction (IGI,IMP) positive regulation of superoxide anion generation (ISO) receptor-mediated endocytosis (IMP) signal transduction (IEA)
1.
Functional and physical interactions between formyl-peptide-receptors and scavenger receptor MARCO and their involvement in amyloid beta 1-42-induced signal transduction in glial cells.
Brandenburg LO, etal., J Neurochem. 2010 May;113(3):749-60. doi: 10.1111/j.1471-4159.2010.06637.x. Epub 2010 Feb 5.
2.
Involvement of formyl-peptide-receptor-like-1 and phospholipase D in the internalization and signal transduction of amyloid beta 1-42 in glial cells.
Brandenburg LO, etal., Neuroscience. 2008 Oct 2;156(2):266-76. doi: 10.1016/j.neuroscience.2008.07.042. Epub 2008 Aug 5.
3.
Detrimental Role of miRNA-144-3p in Intracerebral Hemorrhage Induced Secondary Brain Injury is Mediated by Formyl Peptide Receptor 2 Downregulation Both In Vivo and In Vitro.
Fan W, etal., Cell Transplant. 2018 Dec 4:963689718817219. doi: 10.1177/0963689718817219.
4.
Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium.
Gaudet P, etal., Brief Bioinform. 2011 Sep;12(5):449-62. doi: 10.1093/bib/bbr042. Epub 2011 Aug 27.
5.
Expression and localization of CRAMP in rat tooth germ and during reparative dentin formation.
Horibe K, etal., Clin Oral Investig. 2018 Sep;22(7):2559-2566. doi: 10.1007/s00784-018-2353-x. Epub 2018 Feb 2.
6.
Data Import for Chemical-Gene Interactions
RGD automated import pipeline for gene-chemical interactions
7.
Involvement of formyl peptide receptors in receptor for advanced glycation end products (RAGE)--and amyloid beta 1-42-induced signal transduction in glial cells.
Slowik A, etal., Mol Neurodegener. 2012 Nov 20;7:55. doi: 10.1186/1750-1326-7-55.
Fpr2 Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 1 67,449,637 - 67,458,272 (+) NCBI GRCr8 mRatBN7.2 1 58,776,592 - 58,785,227 (+) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 1 58,776,752 - 58,786,019 (+) Ensembl mRatBN7.2 Ensembl Rnor_6.0 1 59,800,558 - 59,809,507 (-) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 1 59,800,984 - 59,802,401 (-) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 1 60,719,375 - 60,727,932 (-) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 1 56,622,816 - 56,624,057 (+) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 Celera 1 54,955,259 - 54,964,212 (+) NCBI Celera Cytogenetic Map 1 q12 NCBI
FPR2 Human Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCh38 19 51,761,180 - 51,770,531 (+) NCBI GRCh38 GRCh38 hg38 GRCh38 GRCh38.p14 Ensembl 19 51,752,026 - 51,770,531 (+) Ensembl GRCh38 hg38 GRCh38 GRCh37 19 52,264,433 - 52,273,784 (+) NCBI GRCh37 GRCh37 hg19 GRCh37 Build 36 19 56,956,265 - 56,965,591 (+) NCBI NCBI36 Build 36 hg18 NCBI36 Build 34 19 56,958,453 - 56,965,589 NCBI Celera 19 49,314,014 - 49,323,339 (+) NCBI Celera Cytogenetic Map 19 q13.41 NCBI HuRef 19 48,595,209 - 48,604,534 (+) NCBI HuRef CHM1_1 19 52,266,274 - 52,275,599 (+) NCBI CHM1_1 T2T-CHM13v2.0 19 54,839,202 - 54,857,725 (+) NCBI T2T-CHM13v2.0
Fpr2 Mouse Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCm39 17 18,108,086 - 18,114,214 (+) NCBI GRCm39 GRCm39 mm39 GRCm39 Ensembl 17 18,108,086 - 18,114,214 (+) Ensembl GRCm39 Ensembl GRCm38 17 17,887,824 - 17,893,952 (+) NCBI GRCm38 GRCm38 mm10 GRCm38 GRCm38.p6 Ensembl 17 17,887,824 - 17,893,952 (+) Ensembl GRCm38 mm10 GRCm38 MGSCv37 17 18,024,788 - 18,030,916 (+) NCBI GRCm37 MGSCv37 mm9 NCBIm37 MGSCv36 17 17,592,442 - 17,598,570 (+) NCBI MGSCv36 mm8 Celera 17 18,828,566 - 18,834,697 (+) NCBI Celera Cytogenetic Map 17 A3.2 NCBI cM Map 17 10.66 NCBI
FPR2 Bonobo Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl NHGRI_mPanPan1-v2 20 57,795,766 - 57,814,162 (+) NCBI NHGRI_mPanPan1-v2 NHGRI_mPanPan1 19 59,727,403 - 59,738,468 (+) NCBI NHGRI_mPanPan1 Mhudiblu_PPA_v0 19 48,663,622 - 48,715,535 (+) NCBI Mhudiblu_PPA_v0 Mhudiblu_PPA_v0 panPan3 PanPan1.1 19 57,586,681 - 57,593,320 (+) NCBI panpan1.1 PanPan1.1 panPan2
FPR Dog Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl CanFam3.1 1 105,343,096 - 105,353,563 (-) NCBI CanFam3.1 CanFam3.1 canFam3 CanFam3.1 CanFam3.1 Ensembl 1 105,344,463 - 105,372,070 (-) Ensembl CanFam3.1 canFam3 CanFam3.1 Dog10K_Boxer_Tasha 1 104,916,610 - 104,927,170 (-) NCBI Dog10K_Boxer_Tasha ROS_Cfam_1.0 1 105,853,006 - 105,863,566 (-) NCBI ROS_Cfam_1.0 ROS_Cfam_1.0 Ensembl 1 105,855,489 - 105,856,544 (-) Ensembl ROS_Cfam_1.0 Ensembl UMICH_Zoey_3.1 1 105,525,388 - 105,535,950 (-) NCBI UMICH_Zoey_3.1 UNSW_CanFamBas_1.0 1 105,164,383 - 105,175,163 (-) NCBI UNSW_CanFamBas_1.0 UU_Cfam_GSD_1.0 1 105,961,120 - 105,971,680 (-) NCBI UU_Cfam_GSD_1.0
FPR2 Green Monkey Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChlSab1.1 6 44,580,342 - 44,591,187 (+) NCBI ChlSab1.1 ChlSab1.1 chlSab2 ChlSab1.1 Ensembl 6 44,589,334 - 44,590,389 (+) Ensembl ChlSab1.1 ChlSab1.1 Ensembl chlSab2 Vero_WHO_p1.0 NW_023666073 24,634,825 - 24,645,669 (+) NCBI Vero_WHO_p1.0 Vero_WHO_p1.0
Fpr2
.
1331732 Srn4 Serum renin concentration QTL 4 4.467 renin activity (VT:0005581) plasma renin activity level (CMO:0000116) 1 35239598 78430678 Rat 2313059 Bss55 Bone structure and strength QTL 55 3.2 0.0001 tibia size trait (VT:0100001) tibia midshaft cross-sectional area (CMO:0001717) 1 43284731 118944897 Rat 631688 Hcas2 Hepatocarcinoma susceptibility QTL 2 3 0.0001 liver integrity trait (VT:0010547) liver tumorous lesion number (CMO:0001068) 1 5925874 115540829 Rat 1578649 Bmd8 Bone mineral density QTL 8 4.9 femur mineral mass (VT:0010011) trabecular volumetric bone mineral density (CMO:0001729) 1 49393172 94393172 Rat 1358359 Sradr1 Stress Responsive Adrenal Weight QTL 1 4.74 adrenal gland mass (VT:0010420) both adrenal glands wet weight (CMO:0000164) 1 30882023 123479925 Rat 634314 Niddm44 Non-insulin dependent diabetes mellitus QTL 44 blood glucose amount (VT:0000188) blood glucose level (CMO:0000046) 1 49393289 199050459 Rat 4889929 Bss87 Bone structure and strength QTL 87 6.7 tibia area (VT:1000281) tibia-fibula cortical bone endosteal cross-sectional area (CMO:0001722) 1 53895117 82174945 Rat 1331792 Rf29 Renal function QTL 29 4.589 urine potassium amount (VT:0010539) urine potassium level (CMO:0000128) 1 35239598 78430678 Rat 2313062 Bmd73 Bone mineral density QTL 73 3.9 0.0001 tibia mineral mass (VT:1000283) compact volumetric bone mineral density (CMO:0001730) 1 11481312 82174945 Rat 8552900 Pigfal1 Plasma insulin-like growth factor 1 level QTL 1 7.4 blood insulin-like growth factor amount (VT:0010479) plasma insulin-like growth factor 1 level (CMO:0001299) 1 34836858 79836858 Rat 1578654 Bss10 Bone structure and strength QTL 10 4 femur morphology trait (VT:0000559) femoral neck cortical cross-sectional area (CMO:0001702) 1 49393172 159356837 Rat 1554320 Bmd1 Bone mineral density QTL 1 12.2 0.0001 femur mineral mass (VT:0010011) volumetric bone mineral density (CMO:0001553) 1 509108 86060548 Rat 1354643 Foco2 Food consumption QTL 2 7.17 0.0001 eating behavior trait (VT:0001431) food intake rate (CMO:0000427) 1 33449848 78449848 Rat 2302059 Pia36 Pristane induced arthritis QTL 36 3.8 0.001 blood immunoglobulin amount (VT:0002460) serum immunoglobulin G1 level (CMO:0002115) 1 43333002 88333002 Rat 2313065 Bss67 Bone structure and strength QTL 67 3.1 0.0001 tibia area (VT:1000281) tibia total energy absorbed before break (CMO:0001736) 1 11481312 82174945 Rat 1357400 Bw62 Body weight QTL62 4.05 inguinal fat pad mass (VT:0010424) inguinal fat pad weight to body weight ratio (CMO:0001253) 1 22340647 67340647 Rat 2313069 Bss68 Bone structure and strength QTL 68 2.9 0.0001 tibia size trait (VT:0100001) tibia total energy absorbed before break (CMO:0001736) 1 11481312 82174945 Rat 631495 Bp96 Blood pressure QTL 96 4.52 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 1 22340647 102268831 Rat 2313075 Bss66 Bone structure and strength QTL 66 3.4 0.0001 tibia length (VT:0004357) tibia length (CMO:0000450) 1 11481312 82174945 Rat 70225 Bp58 Blood pressure QTL 58 3.3 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 1 32356093 162846471 Rat 2298545 Neuinf8 Neuroinflammation QTL 8 4.6 nervous system integrity trait (VT:0010566) spinal cord beta-2 microglobulin mRNA level (CMO:0002125) 1 57336763 151090257 Rat 2313072 Bss53 Bone structure and strength QTL 53 4.3 0.0001 tibia length (VT:0004357) tibia length (CMO:0000450) 1 43284731 118944897 Rat 1300167 Hrtrt2 Heart rate QTL 2 4.35 heart pumping trait (VT:2000009) heart rate (CMO:0000002) 1 11481312 75088344 Rat 10059597 Bp377 Blood pressure QTL 377 3.42 0.025 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 1 32737458 199368955 Rat 2313078 Bss54 Bone structure and strength QTL 54 3.5 0.0001 tibia area (VT:1000281) tibia midshaft cross-sectional area (CMO:0001717) 1 43284731 118944897 Rat 2313077 Bss69 Bone structure and strength QTL 69 3.5 0.0001 tibia strength trait (VT:1000284) bone polar moment of inertia (CMO:0001558) 1 11481312 82174945 Rat 1331778 Rf28 Renal function QTL 28 4.66 urine potassium amount (VT:0010539) urine potassium excretion rate (CMO:0000761) 1 45803140 78430678 Rat 2313402 Anxrr24 Anxiety related response QTL 24 aggression-related behavior trait (VT:0015014) tameness/aggressiveness composite score (CMO:0002136) 1 48963584 144267916 Rat 1331785 Rf27 Renal function QTL 27 4.643 urine sodium amount (VT:0006274) urine sodium level (CMO:0000129) 1 28879780 78430678 Rat 61342 Bp27 Blood pressure QTL 27 3.4 0.0006 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 1 56732668 98773277 Rat 1300172 Bp172 Blood pressure QTL 172 3.56 arterial blood pressure trait (VT:2000000) diastolic blood pressure (CMO:0000005) 1 32737273 90665040 Rat 4889962 Bss94 Bone structure and strength QTL 94 3.8 tibia area (VT:1000281) tibia-fibula cortical bone endosteal cross-sectional area (CMO:0001722) 1 49361465 82174945 Rat 724520 Bp145 Blood pressure QTL 145 2.1 0.0024 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 1 20784828 65784828 Rat 2313094 Bss58 Bone structure and strength QTL 58 3.7 0.0001 tibia strength trait (VT:1000284) tibia total energy absorbed before break (CMO:0001736) 1 43284731 118944897 Rat 6903308 Scl36 Serum cholesterol QTL 36 2 0.0125 blood cholesterol amount (VT:0000180) plasma total cholesterol level (CMO:0000585) 1 53863041 90532583 Rat 2313092 Bmd72 Bone mineral density QTL 72 2.5 0.0001 tibia mineral mass (VT:1000283) total volumetric bone mineral density (CMO:0001728) 1 11481312 82174945 Rat 2300164 Bmd44 Bone mineral density QTL 44 5.4 0.0001 lumbar vertebra mineral mass (VT:0010511) volumetric bone mineral density (CMO:0001553) 1 56949932 101949932 Rat 2313099 Bss56 Bone structure and strength QTL 56 2.4 0.0001 tibia size trait (VT:0100001) tibia midshaft endosteal cross-sectional area (CMO:0001716) 1 43284731 118944897 Rat 2313098 Bmd70 Bone mineral density QTL 70 3.6 0.0001 tibia mineral mass (VT:1000283) compact volumetric bone mineral density (CMO:0001730) 1 43284731 118944897 Rat 2313097 Bss70 Bone structure and strength QTL 70 3.5 0.0001 tibia strength trait (VT:1000284) tibia total energy absorbed before break (CMO:0001736) 1 11481312 82174945 Rat 9589820 Insglur3 Insulin/glucose ratio QTL 3 10.75 0.001 blood insulin amount (VT:0001560) calculated plasma insulin level (CMO:0002170) 1 34836858 79836858 Rat 152025249 Scl82 Serum cholesterol level QTL 82 4.77 blood cholesterol amount (VT:0000180) 1 50343510 99980958 Rat 738020 Pia8 Pristane induced arthritis QTL 8 4.7 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 1 1 65833076 Rat 1354599 Bw29 Body weight QTL 29 3.46 0.001 body mass (VT:0001259) body weight (CMO:0000012) 1 33449848 78449848 Rat 4889919 Bss86 Bone structure and strength QTL 86 4.1 tibia area (VT:1000281) tibia midshaft total cross-sectional area (CMO:0001715) 1 53895117 82174945 Rat 8552948 Pigfal11 Plasma insulin-like growth factor 1 level QTL 11 4.7 blood insulin-like growth factor amount (VT:0010479) plasma insulin-like growth factor 1 level (CMO:0001299) 1 34836858 79836858 Rat 2313051 Bss57 Bone structure and strength QTL 57 3.7 0.0001 tibia strength trait (VT:1000284) bone polar moment of inertia (CMO:0001558) 1 43284731 118944897 Rat
Click on a value in the shaded box below the category label to view a detailed expression data table for that system.
alimentary part of gastrointestinal system
6
1
36
63
59
62
36
20
36
6
150
73
47
35
37
26
Too many to show, limit is 500. Download them if you would like to view them all.
Ensembl Acc Id:
ENSRNOT00000064917 ⟹ ENSRNOP00000061936
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source Rnor_6.0 Ensembl 1 59,800,984 - 59,802,401 (-) Ensembl
Ensembl Acc Id:
ENSRNOT00000117661 ⟹ ENSRNOP00000094760
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 1 58,776,752 - 58,786,019 (+) Ensembl
RefSeq Acc Id:
NM_001408783 ⟹ NP_001395712
RefSeq Status:
VALIDATED
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 1 67,449,637 - 67,458,272 (+) NCBI mRatBN7.2 1 58,776,592 - 58,785,227 (+) NCBI
Ensembl Acc Id:
ENSRNOP00000061936 ⟸ ENSRNOT00000064917
Ensembl Acc Id:
ENSRNOP00000094760 ⟸ ENSRNOT00000117661
RefSeq Acc Id:
NP_001395712 ⟸ NM_001408783
- UniProtKB:
A0A8I6AM80 (UniProtKB/TrEMBL)
Date
Current Symbol
Current Name
Previous Symbol
Previous Name
Description
Reference
Status
2008-07-08
Fpr2
formyl peptide receptor 2
LOC681693
similar to formyl peptide receptor, related sequence 2
Data merged from RGD:1592850
1643240 APPROVED
2008-05-20
Fpr2
formyl peptide receptor 2
Fpr-rs2
formyl peptide receptor, related sequence 2
Nomenclature updated to reflect human and mouse nomenclature
1299863 APPROVED
2008-03-06
Fpr-rs2
formyl peptide receptor, related sequence 2
LOC690158
similar to formyl peptide receptor, related sequence 2
Nomenclature updated to reflect human and mouse nomenclature
1299863 APPROVED
2006-11-20
LOC681693
similar to formyl peptide receptor, related sequence 2
Symbol and Name status set to provisional
70820 PROVISIONAL
2006-11-19
LOC690158
similar to formyl peptide receptor, related sequence 2
Symbol and Name status set to provisional
70820 PROVISIONAL
